Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
RARX | Ra Pharmaceuticals, Inc. | Read Simon | Chief Scientific Officer | Apr 02, 2020 | Option Exercise | $48.00 | 12,595 | 604,560 | 0 | Apr 03, 2020, 09:02 AM | |
RARX | Ra Pharmaceuticals, Inc. | Read Simon | Chief Scientific Officer | Dec 17, 2019 | Option Exercise | $24.98 | 20,000 | 499,521 | 16,234 | Dec 18, 2019, 06:01 PM | |
RARX | Ra Pharmaceuticals, Inc. | Read Simon | Chief Scientific Officer | Nov 14, 2019 | Option Exercise | $24.78 | 20,000 | 495,508 | 16,234 | Nov 18, 2019, 05:07 PM | |
RARX | Ra Pharmaceuticals, Inc. | Read Simon | Chief Scientific Officer | Oct 16, 2019 | Option Exercise | $24.87 | 20,000 | 497,426 | 16,234 | Oct 17, 2019, 07:00 PM | |
RARX | Ra Pharmaceuticals, Inc. | Read Simon | Chief Scientific Officer | Sep 12, 2019 | Option Exercise | $14.14 | 20,000 | 282,750 | 16,234 | Sep 16, 2019, 06:43 PM | |
RARX | Ra Pharmaceuticals, Inc. | Read Simon | Chief Scientific Officer | Aug 23, 2019 | Sale | $15.32 | 20,000 | 306,403 | 16,234 | Aug 27, 2019, 06:01 PM | |
RARX | Ra Pharmaceuticals, Inc. | Read Simon | Chief Scientific Officer | Jul 17, 2019 | Sale | $17.91 | 20,000 | 358,179 | 16,234 | Jul 18, 2019, 07:04 PM | |
RARX | Ra Pharmaceuticals, Inc. | Read Simon | Chief Scientific Officer | Jun 18, 2019 | Sale | $12.56 | 20,000 | 251,167 | 16,234 | Jun 19, 2019, 09:03 PM | |
RARX | Ra Pharmaceuticals, Inc. | Read Simon | Chief Scientific Officer | Feb 01, 2019 | Option Exercise | $21.00 | 2,933 | 61,593 | 6,234 | Feb 05, 2019, 07:39 PM |